Market Reports /
by Melissa Darmawan -
9 days ago
07 Jan 2021 - It has been a terrific day of trade for the ASX. After opening modestly higher, the ASX 200 shot up in the first 10 minutes of trade, then gained momentum at a steady…
Company News /
by Melissa Darmawan -
9 days ago
07 Jan 2021 - Alterity Therapeutics (ASX:ATH) has appointed Dr David Stamler as chief executive officer to start today.
Company Presentations /
by -
A month ago
09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler presents an overview of the company, discussing Parkinsonian disorders, progress with the co…
Interviews /
by Rachael Jones -
A month ago
09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its du…
Company Presentations /
by -
A year ago
09 Jul 2019 - Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, presents on the company's lead drug candidate, the potential applications for the drug and t…
Interviews /
by Katrina Bullock -
A year ago
09 Jul 2019 - Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, discusses the company’s development pipeline and lead drug candidate PTB434 for use treating…
